MGTXMeiraGTx Holdings plc

14.34USD-4.21%Mkt Cap: 1.38B $P/E: 16.48

MeiraGTx Holdings plc, a clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited ret…

Key Statistics

Company
Market Cap1.38B $
Enterprise Value1.37B $
Revenue (TTM)397.50M $
Gross Profit76.55M $
Net Income (TTM)-114.20M $
Revenue/Share4.748 USD
Last Price14.34 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees393
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINKYG596651029
Valuation
P/E (Trailing)16.48
P/E (Forward)-10.46
PEG
EV/EBITDA6.96
EV/Revenue3.44
P/S3.51
P/B6.35
EPS (TTM)0.84
EPS (Forward)-1.39
52W Range
6.62088% of range15.35
52W High15.35 USD
52W Low6.620 USD
Profitability
Gross Margin94.05%
Oper. Margin76.04%
EBITDA Margin49.34%
Profit Margin-140.31%
ROE1971.36%
ROA-46.72%
Growth
Revenue Growth8608.60%
Earnings Growth
Cash Flow & Leverage
Operating CF-46.36M $
CapEx (TTM)4.24M $
FCF Margin14.19%
FCF Yield4.10%
Net Debt-30.84M $
Net Debt/EBITDA-0.16
Balance Sheet
Debt/Equity-15.31
Current Ratio3.76
Quick Ratio3.23
Book Value/Sh2.289 USD
Cash/Share1.491 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)29.43 USD
Upside (mean)+105.2%
Target Range19.00 USD50.00 USD
$19.00+105.2% to mean$50.00
# Analysts7
Ownership
Shares Out.96.04M
Float53.68M
Insiders16.39%
Institutions70.36%
Short Interest
Short Ratio4.7d
Short % Float5.96%
Short % Out.4.21%
Shares Short3.90M
Short (prev mo.)4.72M
Technical
SMA 5012.36 (+16.0%)
SMA 2009.401 (+52.5%)
Beta1.25
S&P 52W Chg18.16%
Avg Vol (30d)571.52K
Avg Vol (10d)642.23K
Technical Indicators
RSI (14)64.9
MACD0.5500
MACD Signal0.3575
MACD Hist.+0.1925
BB Upper14.53 USD
BB Middle12.71 USD
BB Lower10.90 USD
BB Width28.54%
ATR (14)0.7592 USD
Vol Ratio (20d)1.22x